United States Biotechnology & Medical Research

BioCryst Pharmaceuticals Inc (BCRX)

Track

Track

BioCryst Pharmaceuticals experienced multiple divestments by corporate insiders, with the most recent activity occurring on May 18, 2026. These transactions primarily involved planned or proposed sales of equity by directors and officers. No buying behavior was observed during this period, reflecting a consistent pattern of liquidation among key leadership personnel.
Ticker: BCRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for BioCryst Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
McKee Amy E Non-Executive Director
Transaction date
Sale
Price
216.39
Quantity 35,624 -28.7%
Value US$330,810
1.9
Amy McKee Director Non-Executive Director
Transaction date
Proposed sale
Price
90.58
Quantity 86,543
Value US$2,330,268
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
94.58
Quantity 22,254 -49.5%
Value US$4,958,567
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
9.54
Quantity 62,500
Value US$596,250
3.5
HEGGIE THERESA Non-Executive Director
Transaction date
Sale
Price
10.11
Quantity 49,933 -43.3%
Value US$504,823
3.5
HEGGIE THERESA Director Non-Executive Director
Transaction date
Proposed sale
Price
10.11
Quantity 49,933
Value US$504,620
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
9.15
Quantity 150,000 -27.2%
Value US$1,372,500
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
9.15
Quantity 150,000
Value US$1,372,007
3.3
Stonehouse Jon P Director Non-Executive Director
Transaction date
Proposed sale
Price
8.65
Quantity 305,995
Value US$2,646,857
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.65
Quantity 21,773 -5.2%
Value US$166,563
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
7.65
Quantity 21,773
Value US$166,563
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.65
Quantity 21,210 -6.3%
Value US$162,256
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
7.65
Quantity 21,210
Value US$162,256
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
7.65
Quantity 19,770
Value US$151,240
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.65
Quantity 19,770 -5.4%
Value US$151,240
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Sale
Price
7.21
Quantity 50,906 -12.2%
Value US$367,216
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
7.21
Quantity 50,906
Value US$367,216
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.10
Quantity 91,004 -17.9%
Value US$646,511
2.0
Barnes Alane P Officer Officer
Transaction date
Proposed sale
Price
7.08
Quantity 91,004
Value US$644,308
3.6
Helen M Thackray Officer Officer
Transaction date
Proposed sale
Price
6.80
Quantity 48,229
Value US$327,957
3.6
Helen Thackray Officer Officer
Transaction date
Proposed sale
Price
7.11
Quantity 43,275
Value US$307,685
2.2
SANDERS MACHELLE Non-Executive Director
Transaction date
Planned sale
Price
7.14
Quantity 9,600 -23.9%
Value US$68,544
2.2
SANDERS MACHELLE Officer Officer
Transaction date
Proposed sale
Price
7.14
Quantity 9,600
Value US$68,544
3.5
HEGGIE THERESA Non-Executive Director
Transaction date
Sale
Price
8.51
Quantity 70,000 -51.7%
Value US$595,868
3.5
HEGGIE THERESA Director Non-Executive Director
Transaction date
Proposed sale
Price
8.51
Quantity 70,000
Value US$595,871
3.7
Hutson Nancy J Non-Executive Director
Transaction date
Planned sale
Price
7.54
Quantity 7,000 -7.5%
Value US$52,780
3.7
Hutson Nancy J Director Non-Executive Director
Transaction date
Proposed sale
Price
7.51
Quantity 7,000
Value US$52,584
1.9
McKee Amy E Non-Executive Director
Transaction date
Sale
Price
6.32
Quantity 8,600 -23.6%
Value US$54,352
1.9
McKee Amy E Director Non-Executive Director
Transaction date
Proposed sale
Price
6.29
Quantity 8,600
Value US$54,075
2.2
SANDERS MACHELLE Director Non-Executive Director
Transaction date
Proposed sale
Price
5.97
Quantity 4,689
Value US$27,995
2.2
SANDERS MACHELLE Non-Executive Director
Transaction date
Sale
Price
6.00
Quantity 4,689 -14.5%
Value US$28,134
3.5
HEGGIE THERESA Director Non-Executive Director
Transaction date
Proposed sale
Price
6.08
Quantity 6,698
Value US$40,746
3.5
HEGGIE THERESA Non-Executive Director
Transaction date
Sale
Price
6.11
Quantity 6,698 -11.2%
Value US$40,925
3.1
LEVIN ALAN G Non-Executive Director
Transaction date
Purchase
Price
6.36
Quantity 7,861 +21.2%
Value US$49,996
3.4
ASELAGE STEVE Non-Executive Director
Transaction date
Purchase
Price
6.40
Quantity 2,500 +inf%
Value US$16,000
3.7
Hutson Nancy J Non-Executive Director
Transaction date
Purchase
Price
6.38
Quantity 5,000 +6.1%
Value US$31,900
3.4
MILANO VINCENT Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 15,000 +28.8%
Value US$93,750
3.4
MILANO VINCENT Non-Executive Director
Transaction date
Purchase
Price
6.25
Quantity 15,000 +28.8%
Value US$93,750
3.6
Thackray Helen M. Chief R&D Officer Officer
Transaction date
Purchase
Price
5.86
Quantity 30,000 +12.4%
Value US$175,800
3.7
Doyle Anthony Chief Financial Officer Officer
Transaction date
Purchase
Price
5.57
Quantity 36,300 +15.8%
Value US$202,191
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Purchase
Price
5.53
Quantity 5,000 +1.7%
Value US$27,650
3.3
Stonehouse Jon P President & CEO Executive Director
Transaction date
Purchase
Price
5.55
Quantity 30,000 +2.7%
Value US$166,500
3.3
Gayer Charles K Chief Commercial Officer Officer
Transaction date
Purchase
Price
5.47
Quantity 30,000 +10.8%
Value US$164,100
3.3
Galson Steven K Non-Executive Director
Transaction date
Purchase
Price
5.49
Quantity 21,940 +74.1%
Value US$120,451
2.2
SANDERS MACHELLE Officer Officer
Transaction date
Proposed sale
Price
7.94
Quantity 4,000
Value US$31,779
2.2
SANDERS MACHELLE Non-Executive Director
Transaction date
Sale
Price
7.98
Quantity 4,000 -13.5%
Value US$31,920
3.7
Hutson Nancy J Non-Executive Director
Transaction date
Sale
Price
8.04
Quantity 12,866 -13.6%
Value US$103,443
3.7
Hutson Nancy J Officer Officer
Transaction date
Proposed sale
Price
8.08
Quantity 12,866
Value US$103,957
3.6
Thackray Helen M. Chief R&D Officer Officer
Transaction date
Planned sale
Price
8.29
Quantity 7,000 -3.3%
Value US$58,030
3.3
Stonehouse Jon P President & CEO Executive Director
Transaction date
Planned sale
Price
10.38
Quantity 100,000 -9.0%
Value US$1,038,000
3.6
Thackray Helen M. Chief R&D Officer Officer
Transaction date
Planned sale
Price
10.89
Quantity 3,125 -2.3%
Value US$34,031
3.3
Stonehouse Jon P President & CEO Executive Director
Transaction date
Planned sale
Price
10.90
Quantity 14,100 -1.6%
Value US$153,690
3.3
Gayer Charles K Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.90
Quantity 6,100 -2.8%
Value US$66,490
3.7
Jones Michael L Exec. Director, Finance - PAO Officer
Transaction date
Planned sale
Price
10.90
Quantity 445 -4.0%
Value US$4,850
2.0
Barnes Alane P Chief Legal Officer Officer
Transaction date
Planned sale
Price
10.88
Quantity 4,175 -2.1%
Value US$45,424
3.7
Doyle Anthony Chief Financial Officer Officer
Transaction date
Planned sale
Price
10.90
Quantity 5,700 -3.4%
Value US$62,130
3.3
Stonehouse Jon P President & CEO Executive Director
Transaction date
Planned sale
Price
12.80
Quantity 82,656 -8.4%
Value US$1,057,997
3.3
Stonehouse Jon P President & CEO Executive Director
Transaction date
Planned sale
Price
13.00
Quantity 214,917 -19.2%
Value US$2,793,921
3.7
Jones Michael L Exec. Director, Finance - PAO Officer
Transaction date
Sale
Price
13.01
Quantity 8,600 -43.4%
Value US$111,886
3.3
Babu Yarlagadda S Chief Discovery Officer Officer
Transaction date
Sale
Price
13.88
Quantity 31,515 -9.5%
Value US$437,428
2.9
ABERCROMBIE GEORGE B Non-Executive Director
Transaction date
Planned sale
Price
11.04
Quantity 5,000 -100.0%
Value US$55,200
3.6
Thackray Helen M. Chief R&D Officer Officer
Transaction date
Planned sale
Price
16.20
Quantity 7,600 -5.3%
Value US$123,120
3.3
Sheridan William P Chief Medical Officer Officer
Transaction date
Sale
Price
17.64
Quantity 1,400 -3.6%
Value US$24,696
3.3
Sheridan William P Chief Medical Officer Officer
Transaction date
Sale
Price
16.87
Quantity 159,739 -80.2%
Value US$2,694,797
3.3
Babu Yarlagadda S Chief Discovery Officer Officer
Transaction date
Sale
Price
17.16
Quantity 20,000 -8.0%
Value US$343,200
3.7
Jones Michael L Exec. Director, Finance - PAO Officer
Transaction date
Sale
Price
17.20
Quantity 2,300 -17.0%
Value US$39,560
2.9
ABERCROMBIE GEORGE B Non-Executive Director
Transaction date
Planned sale
Price
18.50
Quantity 5,000 -100.0%
Value US$92,500
3.3
Stonehouse Jon P President & CEO Executive Director
Transaction date
Planned sale
Price
15.04
Quantity 184,000 -16.9%
Value US$2,767,360
3.3
Babu Yarlagadda S Chief Discovery Officer Officer
Transaction date
Sale
Price
12.20
Quantity 30,100 -12.3%
Value US$367,220
3.4
MILANO VINCENT Non-Executive Director
Transaction date
Purchase
Price
12.19
Quantity 7,500 +75.0%
Value US$91,425
3.7
Doyle Anthony Chief Financial Officer Officer
Transaction date
Purchase
Price
12.48
Quantity 35,258 +60.3%
Value US$440,020
2.9
ABERCROMBIE GEORGE B Non-Executive Director
Transaction date
Planned sale
Price
12.27
Quantity 5,000 -100.0%
Value US$61,350
3.7
Hutson Nancy J Non-Executive Director
Transaction date
Planned sale
Price
15.40
Quantity 105,000 -61.7%
Value US$1,617,000
2.9
ABERCROMBIE GEORGE B Non-Executive Director
Transaction date
Planned sale
Price
15.06
Quantity 5,000 -100.0%
Value US$75,300
2.9
ABERCROMBIE GEORGE B Non-Executive Director
Transaction date
Sale
Price
15.09
Quantity 74,000 -100.0%
Value US$1,116,660
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-18 S Sale
1.9
McKee Amy E
Non-Executive Director
35,624 -28.7%
216.39
US$330,810 		35,624 -28.7% 216.39 US$330,810
2026-05-18 2026-05-18 PrS Proposed sale
1.9
Amy McKee

Director

Non-Executive Director
86,543
90.58
US$2,330,268 		86,543 90.58 US$2,330,268
2026-05-15 2026-05-13 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
22,254 -49.5%
94.58
US$4,958,567 		22,254 -49.5% 94.58 US$4,958,567
2026-05-13 2026-05-13 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
62,500
9.54
US$596,250 		62,500 9.54 US$596,250
2026-03-24 2026-03-20 S Sale
3.5
HEGGIE THERESA
Non-Executive Director
49,933 -43.3%
10.11
US$504,823 		49,933 -43.3% 10.11 US$504,823
2026-03-20 2026-03-20 PrS Proposed sale
3.5
HEGGIE THERESA

Director

Non-Executive Director
49,933
10.11
US$504,620 		49,933 10.11 US$504,620
2026-03-18 2026-03-16 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
150,000 -27.2%
9.15
US$1,372,500 		150,000 -27.2% 9.15 US$1,372,500
2026-03-16 2026-03-16 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
150,000
9.15
US$1,372,007 		150,000 9.15 US$1,372,007
2026-03-02 2026-03-02 PrS Proposed sale
3.3
Stonehouse Jon P

Director

Non-Executive Director
305,995
8.65
US$2,646,857 		305,995 8.65 US$2,646,857
2025-12-23 2025-12-22 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
21,773 -5.2%
7.65
US$166,563 		21,773 -5.2% 7.65 US$166,563
2025-12-22 2025-12-22 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
21,773
7.65
US$166,563 		21,773 7.65 US$166,563
2025-12-16 2025-12-15 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
21,210 -6.3%
7.65
US$162,256 		21,210 -6.3% 7.65 US$162,256
2025-12-15 2025-12-15 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
21,210
7.65
US$162,256 		21,210 7.65 US$162,256
2025-12-03 2025-12-03 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
19,770
7.65
US$151,240 		19,770 7.65 US$151,240
2025-12-03 2025-12-03 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
19,770 -5.4%
7.65
US$151,240 		19,770 -5.4% 7.65 US$151,240
2025-12-03 2025-12-02 S Sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
50,906 -12.2%
7.21
US$367,216 		50,906 -12.2% 7.21 US$367,216
2025-12-02 2025-12-02 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
50,906
7.21
US$367,216 		50,906 7.21 US$367,216
2025-12-03 2025-12-01 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
91,004 -17.9%
7.10
US$646,511 		91,004 -17.9% 7.10 US$646,511
2025-12-01 2025-12-01 PrS Proposed sale
2.0
Barnes Alane P

Officer

Officer
91,004
7.08
US$644,308 		91,004 7.08 US$644,308
2025-11-25 2025-11-25 PrS Proposed sale
3.6
Helen M Thackray

Officer

Officer
48,229
6.80
US$327,957 		48,229 6.80 US$327,957
2025-11-21 2025-11-21 PrS Proposed sale
3.6
Helen Thackray

Officer

Officer
43,275
7.11
US$307,685 		43,275 7.11 US$307,685
2025-11-17 2025-11-13 PlS Planned sale
2.2
SANDERS MACHELLE
Non-Executive Director
9,600 -23.9%
7.14
US$68,544 		9,600 -23.9% 7.14 US$68,544
2025-11-13 2025-11-13 PrS Proposed sale
2.2
SANDERS MACHELLE

Officer

Officer
9,600
7.14
US$68,544 		9,600 7.14 US$68,544
2025-08-15 2025-08-13 S Sale
3.5
HEGGIE THERESA
Non-Executive Director
70,000 -51.7%
8.51
US$595,868 		70,000 -51.7% 8.51 US$595,868
2025-08-13 2025-08-13 PrS Proposed sale
3.5
HEGGIE THERESA

Director

Non-Executive Director
70,000
8.51
US$595,871 		70,000 8.51 US$595,871
2024-12-16 2024-12-13 PlS Planned sale
3.7
Hutson Nancy J
Non-Executive Director
7,000 -7.5%
7.54
US$52,780 		7,000 -7.5% 7.54 US$52,780
2024-12-13 2024-12-13 PrS Proposed sale
3.7
Hutson Nancy J

Director

Non-Executive Director
7,000
7.51
US$52,584 		7,000 7.51 US$52,584
2024-06-25 2024-06-24 S Sale
1.9
McKee Amy E
Non-Executive Director
8,600 -23.6%
6.32
US$54,352 		8,600 -23.6% 6.32 US$54,352
2024-06-24 2024-06-24 PrS Proposed sale
1.9
McKee Amy E

Director

Non-Executive Director
8,600
6.29
US$54,075 		8,600 6.29 US$54,075
2024-06-17 2024-06-17 PrS Proposed sale
2.2
SANDERS MACHELLE

Director

Non-Executive Director
4,689
5.97
US$27,995 		4,689 5.97 US$27,995
2024-06-17 2024-06-17 S Sale
2.2
SANDERS MACHELLE
Non-Executive Director
4,689 -14.5%
6.00
US$28,134 		4,689 -14.5% 6.00 US$28,134
2024-06-14 2024-06-14 PrS Proposed sale
3.5
HEGGIE THERESA

Director

Non-Executive Director
6,698
6.08
US$40,746 		6,698 6.08 US$40,746
2024-06-14 2024-06-14 S Sale
3.5
HEGGIE THERESA
Non-Executive Director
6,698 -11.2%
6.11
US$40,925 		6,698 -11.2% 6.11 US$40,925
2024-05-31 2024-05-30 B Purchase
3.1
LEVIN ALAN G
Non-Executive Director
7,861 +21.2%
6.36
US$49,996 		7,861 +21.2% 6.36 US$49,996
2024-05-29 2024-05-24 B Purchase
3.4
ASELAGE STEVE
Non-Executive Director
2,500 +inf%
6.40
US$16,000 		2,500 +inf% 6.40 US$16,000
2024-05-22 2024-05-20 B Purchase
3.7
Hutson Nancy J
Non-Executive Director
5,000 +6.1%
6.38
US$31,900 		5,000 +6.1% 6.38 US$31,900
2024-05-22 2024-05-20 B Purchase
3.4
MILANO VINCENT
Non-Executive Director
15,000 +28.8%
6.25
US$93,750 		15,000 +28.8% 6.25 US$93,750
2024-05-22 2024-05-20 B Purchase
3.4
MILANO VINCENT
Non-Executive Director
15,000 +28.8%
6.25
US$93,750 		15,000 +28.8% 6.25 US$93,750
2024-05-15 2024-05-14 B Purchase
3.6
Thackray Helen M.

Chief R&D Officer

Officer
30,000 +12.4%
5.86
US$175,800 		30,000 +12.4% 5.86 US$175,800
2024-05-15 2024-05-14 B Purchase
3.7
Doyle Anthony

Chief Financial Officer

Officer
36,300 +15.8%
5.57
US$202,191 		36,300 +15.8% 5.57 US$202,191
2024-05-15 2024-05-13 B Purchase
2.0
Barnes Alane P

Chief Legal Officer

Officer
5,000 +1.7%
5.53
US$27,650 		5,000 +1.7% 5.53 US$27,650
2024-05-15 2024-05-13 B Purchase
3.3
Stonehouse Jon P

President & CEO

Executive Director
30,000 +2.7%
5.55
US$166,500 		30,000 +2.7% 5.55 US$166,500
2024-05-15 2024-05-13 B Purchase
3.3
Gayer Charles K

Chief Commercial Officer

Officer
30,000 +10.8%
5.47
US$164,100 		30,000 +10.8% 5.47 US$164,100
2024-05-15 2024-05-13 B Purchase
3.3
Galson Steven K
Non-Executive Director
21,940 +74.1%
5.49
US$120,451 		21,940 +74.1% 5.49 US$120,451
2023-06-15 2023-06-15 PrS Proposed sale
2.2
SANDERS MACHELLE

Officer

Officer
4,000
7.94
US$31,779 		4,000 7.94 US$31,779
2023-06-15 2023-06-15 S Sale
2.2
SANDERS MACHELLE
Non-Executive Director
4,000 -13.5%
7.98
US$31,920 		4,000 -13.5% 7.98 US$31,920
2023-06-15 2023-06-14 S Sale
3.7
Hutson Nancy J
Non-Executive Director
12,866 -13.6%
8.04
US$103,443 		12,866 -13.6% 8.04 US$103,443
2023-06-14 2023-06-14 PrS Proposed sale
3.7
Hutson Nancy J

Officer

Officer
12,866
8.08
US$103,957 		12,866 8.08 US$103,957
2023-04-05 2023-04-03 PlS Planned sale
3.6
Thackray Helen M.

Chief R&D Officer

Officer
7,000 -3.3%
8.29
US$58,030 		7,000 -3.3% 8.29 US$58,030
2023-02-02 2023-02-01 PlS Planned sale
3.3
Stonehouse Jon P

President & CEO

Executive Director
100,000 -9.0%
10.38
US$1,038,000 		100,000 -9.0% 10.38 US$1,038,000
2022-12-19 2022-12-15 PlS Planned sale
3.6
Thackray Helen M.

Chief R&D Officer

Officer
3,125 -2.3%
10.89
US$34,031 		3,125 -2.3% 10.89 US$34,031
2022-12-19 2022-12-15 PlS Planned sale
3.3
Stonehouse Jon P

President & CEO

Executive Director
14,100 -1.6%
10.90
US$153,690 		14,100 -1.6% 10.90 US$153,690
2022-12-19 2022-12-15 PlS Planned sale
3.3
Gayer Charles K

Chief Commercial Officer

Officer
6,100 -2.8%
10.90
US$66,490 		6,100 -2.8% 10.90 US$66,490
2022-12-19 2022-12-15 PlS Planned sale
3.7
Jones Michael L

Exec. Director, Finance - PAO

Officer
445 -4.0%
10.90
US$4,850 		445 -4.0% 10.90 US$4,850
2022-12-19 2022-12-15 PlS Planned sale
2.0
Barnes Alane P

Chief Legal Officer

Officer
4,175 -2.1%
10.88
US$45,424 		4,175 -2.1% 10.88 US$45,424
2022-12-19 2022-12-15 PlS Planned sale
3.7
Doyle Anthony

Chief Financial Officer

Officer
5,700 -3.4%
10.90
US$62,130 		5,700 -3.4% 10.90 US$62,130
2022-12-02 2022-12-02 PlS Planned sale
3.3
Stonehouse Jon P

President & CEO

Executive Director
82,656 -8.4%
12.80
US$1,057,997 		82,656 -8.4% 12.80 US$1,057,997
2022-12-02 2022-12-01 PlS Planned sale
3.3
Stonehouse Jon P

President & CEO

Executive Director
214,917 -19.2%
13.00
US$2,793,921 		214,917 -19.2% 13.00 US$2,793,921
2022-12-02 2022-12-01 S Sale
3.7
Jones Michael L

Exec. Director, Finance - PAO

Officer
8,600 -43.4%
13.01
US$111,886 		8,600 -43.4% 13.01 US$111,886
2022-11-16 2022-11-14 S Sale
3.3
Babu Yarlagadda S

Chief Discovery Officer

Officer
31,515 -9.5%
13.88
US$437,428 		31,515 -9.5% 13.88 US$437,428
2022-04-20 2022-04-18 PlS Planned sale
2.9
ABERCROMBIE GEORGE B
Non-Executive Director
5,000 -100.0%
11.04
US$55,200 		5,000 -100.0% 11.04 US$55,200
2022-04-04 2022-04-01 PlS Planned sale
3.6
Thackray Helen M.

Chief R&D Officer

Officer
7,600 -5.3%
16.20
US$123,120 		7,600 -5.3% 16.20 US$123,120
2022-03-14 2022-03-10 S Sale
3.3
Sheridan William P

Chief Medical Officer

Officer
1,400 -3.6%
17.64
US$24,696 		1,400 -3.6% 17.64 US$24,696
2022-03-14 2022-03-10 S Sale
3.3
Sheridan William P

Chief Medical Officer

Officer
159,739 -80.2%
16.87
US$2,694,797 		159,739 -80.2% 16.87 US$2,694,797
2022-03-09 2022-03-07 S Sale
3.3
Babu Yarlagadda S

Chief Discovery Officer

Officer
20,000 -8.0%
17.16
US$343,200 		20,000 -8.0% 17.16 US$343,200
2022-03-03 2022-03-01 S Sale
3.7
Jones Michael L

Exec. Director, Finance - PAO

Officer
2,300 -17.0%
17.20
US$39,560 		2,300 -17.0% 17.20 US$39,560
2022-02-16 2022-02-15 PlS Planned sale
2.9
ABERCROMBIE GEORGE B
Non-Executive Director
5,000 -100.0%
18.50
US$92,500 		5,000 -100.0% 18.50 US$92,500
2022-01-13 2022-01-11 PlS Planned sale
3.3
Stonehouse Jon P

President & CEO

Executive Director
184,000 -16.9%
15.04
US$2,767,360 		184,000 -16.9% 15.04 US$2,767,360
2021-12-09 2021-12-07 S Sale
3.3
Babu Yarlagadda S

Chief Discovery Officer

Officer
30,100 -12.3%
12.20
US$367,220 		30,100 -12.3% 12.20 US$367,220
2021-11-24 2021-11-24 B Purchase
3.4
MILANO VINCENT
Non-Executive Director
7,500 +75.0%
12.19
US$91,425 		7,500 +75.0% 12.19 US$91,425
2021-11-24 2021-11-23 B Purchase
3.7
Doyle Anthony

Chief Financial Officer

Officer
35,258 +60.3%
12.48
US$440,020 		35,258 +60.3% 12.48 US$440,020
2021-11-17 2021-11-15 PlS Planned sale
2.9
ABERCROMBIE GEORGE B
Non-Executive Director
5,000 -100.0%
12.27
US$61,350 		5,000 -100.0% 12.27 US$61,350
2021-10-19 2021-10-15 PlS Planned sale
3.7
Hutson Nancy J
Non-Executive Director
105,000 -61.7%
15.40
US$1,617,000 		105,000 -61.7% 15.40 US$1,617,000
2021-09-17 2021-09-15 PlS Planned sale
2.9
ABERCROMBIE GEORGE B
Non-Executive Director
5,000 -100.0%
15.06
US$75,300 		5,000 -100.0% 15.06 US$75,300
2021-09-14 2021-09-10 S Sale
2.9
ABERCROMBIE GEORGE B
Non-Executive Director
74,000 -100.0%
15.09
US$1,116,660 		74,000 -100.0% 15.09 US$1,116,660
Explore more

More insider trading research around BioCryst Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America